These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28042645)

  • 21. Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients.
    Drechsler C; Schneider A; Gutjahr-Lengsfeld L; Kroiss M; Carrero JJ; Krane V; Allolio B; Wanner C; Fassnacht M
    Am J Kidney Dis; 2014 Jun; 63(6):988-96. PubMed ID: 24315768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Normal-range thyroid-stimulating hormone levels and cardiovascular events and mortality in type 2 diabetes.
    de Vries TI; de Valk HW; van der Graaf Y; de Borst GJ; Cramer MJM; Jaap Kappelle L; Visseren FLJ; Westerink J;
    Diabetes Res Clin Pract; 2019 Nov; 157():107880. PubMed ID: 31628967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thyrotropin and thyroid hormone economy in euthyroid Hashimoto's thyroiditis.
    Solter D; Solter M
    Acta Clin Croat; 2015 Mar; 54(1):52-6. PubMed ID: 26058243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroid-Stimulating Hormone and Mild Cognitive Impairment: Results of the Heinz Nixdorf Recall Study.
    Winkler A; Weimar C; Jöckel KH; Erbel R; Dragano N; Broecker-Preuss M; Moebus S; Führer-Sakel D; Dlugaj M
    J Alzheimers Dis; 2016; 49(3):797-807. PubMed ID: 26519440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum thyrotropin as a risk factor for thyroid malignancy in euthyroid subjects with thyroid micronodule.
    Moon SS; Lee YS; Lee IK; Kim JG
    Head Neck; 2012 Jul; 34(7):949-52. PubMed ID: 22127951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of longitudinal trends in thyroid function with incident carotid atherosclerosis in middle-aged and older euthyroid subjects: the Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIH) cohort study.
    Gu Y; Meng G; Zhang Q; Liu L; Wu H; Zhang S; Wang Y; Zhang T; Wang X; Sun S; Wang X; Jia Q; Song K; Liu Q; Niu K
    Age Ageing; 2022 Jan; 51(1):. PubMed ID: 35077556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between thyroid-stimulating hormone and blood pressure in adults: an 11-year longitudinal study.
    Langén VL; Niiranen TJ; Puukka P; Sundvall J; Jula AM
    Clin Endocrinol (Oxf); 2016 May; 84(5):741-7. PubMed ID: 26261034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-response relationship between thyroid stimulating hormone and hypertension risk in euthyroid individuals.
    He W; Li S; Wang B; Mu K; Shao X; Yao Q; Li L; Li Q; Zhang JA
    J Hypertens; 2019 Jan; 37(1):144-153. PubMed ID: 29985205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyroid-stimulating hormone levels within the reference range are associated with serum lipid profiles independent of thyroid hormones.
    Wang F; Tan Y; Wang C; Zhang X; Zhao Y; Song X; Zhang B; Guan Q; Xu J; Zhang J; Zhang D; Lin H; Yu C; Zhao J
    J Clin Endocrinol Metab; 2012 Aug; 97(8):2724-31. PubMed ID: 22730515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Baseline level and change in serum albumin concentration and the risk of incident type 2 diabetes.
    Hwang YC; Jun JE; Hong WJ; Jin SM; Bae JC; Hur KY; Lee MK; Kim JH
    J Diabetes Complications; 2018 Jan; 32(1):61-66. PubMed ID: 29074121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum thyrotropin is a better predictor of future thyroid dysfunction than thyroid autoantibody status in biochemically euthyroid patients with diabetes: implications for screening.
    Warren RE; Perros P; Nyirenda MJ; Frier BM
    Thyroid; 2004 Oct; 14(10):853-7. PubMed ID: 15588383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between changes in oestradiol and follicle-stimulating hormone levels during the menopausal transition and risk of diabetes.
    Park SK; Harlow SD; Zheng H; Karvonen-Gutierrez C; Thurston RC; Ruppert K; Janssen I; Randolph JF
    Diabet Med; 2017 Apr; 34(4):531-538. PubMed ID: 27973745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normal thyroid-stimulating hormone levels, autoimmune activation, and coronary heart disease risk.
    Onat A; Aydın M; Can G; Çelik E; Altay S; Karagöz A; Ademoğlu E
    Endocrine; 2015 Feb; 48(1):218-26. PubMed ID: 24794068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Correlation of thyroid-stimulating hormone with metabolic syndrome in euthyroid male elders].
    Xiao H; Lu Y; Cheng X; Fang F; Gong Y; Li Z; Li J; Tian H; Li C
    Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(14):1055-9. PubMed ID: 24851887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subclinical thyroid dysfunction, cardiac function, and the risk of heart failure. The Cardiovascular Health study.
    Rodondi N; Bauer DC; Cappola AR; Cornuz J; Robbins J; Fried LP; Ladenson PW; Vittinghoff E; Gottdiener JS; Newman AB
    J Am Coll Cardiol; 2008 Sep; 52(14):1152-9. PubMed ID: 18804743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between Thyroid Stimulating Hormone and Renal Function in Euthyroid Residents of Japan: Results from the Kyushu and Okinawa Population Study (KOPS).
    Tanaka Y; Furusyo N; Kato Y; Ueyama T; Yamasaki S; Ikezaki H; Murata M; Hayashi J
    J Atheroscler Thromb; 2018 Apr; 25(4):335-343. PubMed ID: 29046502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of thyroid-stimulating hormone within reference range in patients with coronary artery disease.
    Ndrepepa G; Braun S; Mayer K; Cassese S; Fusaro M; Byrne RA; Hoppmann P; Schunkert H; Laugwitz KL; Kastrati A
    Metabolism; 2015 Oct; 64(10):1308-15. PubMed ID: 26298467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mean platelet volume is significantly associated with serum levels of thyroid-stimulating hormone in a cohort of older euthyroid subjects.
    Lippi G; Danese E; Montagnana M; Nouvenne A; Meschi T; Borghi L
    Endocr Res; 2015; 40(4):227-30. PubMed ID: 26167760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Change in serum thyroid-stimulating hormone concentration in response to administration of thyrotropin-releasing hormone to healthy dogs, hypothyroid dogs, and euthyroid dogs with concurrent disease.
    Scott-Moncrieff JC; Nelson RW
    J Am Vet Med Assoc; 1998 Nov; 213(10):1435-8. PubMed ID: 9828939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thyroid Hormone Therapy and Risk of Thyrotoxicosis in Community-Resident Older Adults: Findings from the Baltimore Longitudinal Study of Aging.
    Mammen JS; McGready J; Oxman R; Chia CW; Ladenson PW; Simonsick EM
    Thyroid; 2015 Sep; 25(9):979-86. PubMed ID: 26177259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.